ICU Medical Announces Third Quarter 2026 Financial Results

ICU Medical reported third-quarter 2026 revenue of $560.4 million, up from $537.0 million a year earlier. GAAP net income was $26.8 million, or $1.07 per diluted share, compared with a net loss of $3.4 million, or $0.14 per share, in the prior-year quarter; adjusted diluted EPS increased to $2.44 from $2.03. The company reaffirmed its 2026 guidance and said it expects results toward the higher end of its previously stated ranges.